Table 3 Proportion of children under 18 years old who have received one-dose and multiple-doses of MCV, and the estimated ‘zero-dose’ population by year

2005

50.1 (43.0—54.4)

45.9 (43.7—49.4)

4.0 (1.9—7.6)

86.7 (79.2—94.0)

2006

47.6 (42.5—51.0)

48.6 (47.0—51.3)

3.5 (2.0—6.2)

87.2 (80.3—94.0)

2007

45.9 (40.9—48.7)

50.7 (49.3—53.2)

3.4 (2.0—5.9)

87.4 (80.7—93.9)

2008

44.4 (39.9—46.9)

52.4 (51.2—54.7)

3.2 (2.0—5.5)

87.6 (81.1—93.9)

2009

43.4 (39.3—45.6)

53.6 (52.5—55.6)

3.0 (1.9—5.0)

87.8 (81.6—94.0)

2010

42.6 (39.0—44.5)

54.7 (53.7—56.4)

2.8 (1.8—4.5)

88.0 (81.8—94.1)

2011

41.6 (38.5—43.3)

55.8 (55.0—57.3)

2.6 (1.8—4.2)

88.2 (81.9—94.2)

2012

39.8 (36.3—42.6)

57.7 (55.6—59.8)

2.5 (1.7—3.9)

91.5 (86.3—95.7)

2013

40.8 (37.9—42.2)

56.7 (56.0—58.1)

2.5 (1.8—4.0)

91.4 (86.2—95.7)

2014

39.8 (37.9—41.8)

57.9 (56.5—58.8)

2.3 (1.6—3.7)

91.6 (86.4—95.9)

2015

39.6 (37.8—41.4)

58.1 (56.8—58.9)

2.3 (1.7—3.7)

91.6 (86.4—96.0)

2016

39.5 (38.6—40.7)

58.8 (57.8—59.9)

1.7 (1.3—2.6)

92.2 (87.1—96.1)

2017

39.1 (37.2—40.2)

59.8 (58.8—61.1)

1.2 (0.9—1.7)

92.8 (87.7—96.6)

2018

39.8 (37.6—40.9)

59.3 (58.5—60.6)

0.9 (0.5—1.8)

93.1 (87.9—97.0)

2019

40.3 (38.2 – 41.4)

58.9 (58.0—60.1)

0.9 (0.5—1.7)

93.1 (88.0—97.0)

2020

41.5 (40.3—42.0)

57.5 (57.2—58.0)

1.0 (0.6—1.7)

92.9 (87.9—96.8)

2021

42.2 (40.8—42.9)

56.8 (56.4 – 57.4)

1.1 (0.6—1.9)

92.9 (87.8—96.8)